Human renal cell adenocarcinoma cells (ACHN Luc)

The application of ACHN Luc human renal cell adenocarcinoma cells provides pivotal insights in cancer research particularly by enabling scientists to study the efficacy of novel therapeutic agents and treatment protocols in a controlled environment Using these epithelioid adherent cells preserved on dry ice or transported in live cell conditions researchers can effectively investigate the underlying mechanisms of renal cancer progression and metastasis The cells are cultured with optimized media consisting of 90% DMEM and 10% FBS promoting robust growth and functionality necessary for drug testing and gene expression analysis

In drug development ACHN Luc cells serve as an invaluable model for screening potential anti-cancer compounds and assessing their pharmacological effects facilitating the identification of promising candidates for further clinical study Moreover the incorporation of luciferase expression within ACHN Luc cells allows for real-time monitoring of cellular behavior and drug response significantly enhancing the understanding of therapeutic impacts in a non-invasive manner

Furthermore the utilization of these cells in collaborative research enhances the study of cancer biology ultimately contributing to the advancement of tailored treatment strategies aimed at improving patient outcomes in renal cell carcinoma